Company Encyclopedia
View More
name
General Healthy
605186.SH
Shanghai General Healthy Information and Technology Co., Ltd. provides pharmaceutical logistics automation, information technology, and intelligent and mobile medical solutions in China. The company’s products include the Smart Pharmacy Project, an intelligent drug management system that combines software and hardware; intelligent static distribution center project, an intelligent intravenous drug configuration and management system; and Intelligent Drug Consumables Management Project, a management system for drug consumables, including poisonous hemp drugs and high-value medical consumables. The company was founded in 2014 and is based in Shanghai, China.
911.88 B
605186.SHMarket value -Rank by Market Cap -/-

Financial Score

20/11/2025 Update
B
Health Care EquipmentIndustry
Industry Ranking24/63
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE0.83%D
    • Profit Margin2.27%C
    • Gross Margin32.31%C
  • Growth ScoreB
    • Revenue YoY50.48%A
    • Net Profit YoY-50.45%D
    • Total Assets YoY10.04%B
    • Net Assets YoY1.25%C
  • Cash ScoreA
    • Cash Flow Margin4411.99%A
    • OCF YoY50.48%A
  • Operating ScoreD
    • Turnover0.26D
  • Debt ScoreB
    • Gearing Ratio26.52%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    General Healthy released its performance for the first half of the year, with a net profit attributable to the parent company of 5.0252 million yuan, a year-on-year decrease of 82.99%

    General Healthy released its performance for the first half of the year, with a net profit attributable to the parent company of 5.0252 million yuan, a year-on-year decrease of 82.99%

    Zhitong·
    SH
    605186
    +0.47%
    Zhitong·
    SH
    605186
    +0.47%

    General Healthy plans to transfer its 15 million shares of Hongsheng Houde Fund

    According to the Zhitong Finance APP, General Healthy announced that the company will transfer its 15 million shares of Shanghai Hongsheng Houde Private Investment Fund Partnership (Limited Partnership) (hereinafter referred to as "Hongsheng Houde") that have not yet been fully paid to Huang Zhihong, with a transfer price of RMB 0. After the completion of the above property share transfer, the company will hold 15 million shares of the Hongsheng Houde fund

    Zhitong·
    SH
    605186
    +0.47%
    Zhitong·
    SH
    605186
    +0.47%

    General Healthy: It is expected that the net profit in the first half of 2025 will decrease by 72.92% to 83.08% year-on-year

    General Healthy expects its net profit in the first half of 2025 to decrease by 72.92% to 83.08% year-on-year, with a projected net profit attributable to the owners of the parent company of 5 million to 8 million yuan, a decrease of 21.5444 million to 24.5444 million yuan. The net profit after deducting non-recurring gains and losses is expected to be 4.8 million to 7.8 million yuan, a year-on-year decrease of 65.11% to 78.53%

    Zhitong·
    SH
    605186
    +0.47%
    Zhitong·
    SH
    605186
    +0.47%

    General Healthy: Some fundraising projects postponed to February 2026

    General Healthy announced that, based on the current implementation progress of the fundraising projects, it intends to extend the construction deadline for the "Pharmacy Automation Upgrade R&D Project" and the "Automated Equipment Deployment Project" from March 2025 to February 2026. This extension is mainly due to the slowdown in demand for automation in the domestic pharmacy automation field and the slow recovery of funding for medical institutions. The company has re-evaluated these two projects and believes that their feasibility and expected returns have not changed significantly, therefore it has decided to continue implementing the aforementioned fundraising investment projects

    Zhitong·
    SH
    605186
    +0.47%
    Zhitong·
    SH
    605186
    +0.47%